Since launching the stock buyback program in 2014, UHS has repurchased about 10 million shares of its Class B Common Stock. The company repurchased 2.1 million shares in the first nine months of this year.
UHS reported a profit of $171.75 million on revenues of $2.65 billion in the third quarter of this year. In the same period of 2017, the company recorded a profit of $141.25 million on revenues $2.54 billion.
More articles on healthcare finance:
Trinity Health gets $86M revenue boost from new hospital
Private equity pushes into healthcare: 9 latest deals
UPMC Pinnacle to close hospital
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
